🇺🇸 FDA
Pipeline program

Human amniotic epithelial stem cells(hAESCs)

NFEC-2019-128

Phase 1 mab terminated

Quick answer

Human amniotic epithelial stem cells(hAESCs) for Acute Graft Versus Host Disease is a Phase 1 program (mab) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Acute Graft Versus Host Disease
Phase
Phase 1
Modality
mab
Status
terminated

Clinical trials